Latest news
BioMarin Pharmaceutical (0HNC) Q4 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 22:26:24 GMTBioMarin Pharmaceutical (0HNC) Q1 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 18:41:16 GMTBioMarin Pharmaceutical (0HNC) Q3 2025 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 17:58:15 GMTBioMarin Pharmaceutical (0HNC) Q4 2024 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 17:54:18 GMTBioMarin Pharmaceutical (0HNC) Q1 2026 Earnings Report - Results, Call & Slides - TipRanksTipRanks · Sat, 08 Aug 2026 13:55:35 GMTBioMarin Buy Rating Reaffirmed as Strong Voxzogo Performance and Pipeline Progress Support Durable Growth; $94 Price Target Maintained - TipRanksTipRanks · Fri, 07 Aug 2026 15:52:41 GMTBioMarin Stock Stumbles Despite Upbeat 2026 Outlook - TipRanksTipRanks · Fri, 07 Aug 2026 05:06:29 GMT